CRISPR/Cas۱۳: Revolutionizing Bacterial Detection and Diagnostics

سال انتشار: 1402
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 103

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

MEDISM24_335

تاریخ نمایه سازی: 6 اسفند 1402

چکیده مقاله:

BACKGROUND AND OBJECTIVESThe emergence of CRISPR/Cas۱۳ technology has revolutionized the field of molecular diagnostics, providing a powerful tool for the detection of bacterial pathogens. With its precision and high sensitivity, CRISPR/Cas۱۳ offers new possibilities in the fight against infectious diseases. In this article, we will explore the applications, advantages, challenges, future directions, and impact of CRISPR/Cas۱۳ in bacterial detection.Applications and Advantages:CRISPR/Cas۱۳ offers diverse applications in bacterial detection. By targeting specific bacterial RNA sequences, Cas۱۳ protein can be guided to cleave the targeted RNA molecules in a highly specific manner. This enables researchers to create novel diagnostic assays for detecting bacterial infections. The advantages of CRISPR/Cas۱۳ for bacterial detection include its rapidity, scalability, and high sensitivity. It allows for the detection of multiple bacterial species in a single assay, reducing the turnaround time and cost.Challenges:While CRISPR/Cas۱۳ presents immense potential, it also faces certain challenges. One major challenge is the need for comprehensive databases of bacterial RNA sequences. To accurately identify bacterial pathogens, extensive databases are required to guide Cas۱۳ to specifically recognize and cleave the target sequences. Additionally, the delivery of Cas۱۳ and guide RNA into the target cells poses a technical challenge that needs to be addressed for efficient and safe bacterial detection.Future Directions:The future of CRISPR/Cas۱۳ in bacterial detection looks promising. Scientists are continuously improving the technology's efficiency and expanding its applications. Efforts are being made to enhance the sensitivity and specificity of CRISPR/Cas۱۳-based assays, opening doors to more accurate and reliable bacterial detection. Additionally, the integration of CRISPR/Cas۱۳ with other diagnostic platforms, such as microfluidics and point-of-care devices, holds the potential for rapid and accessible bacterial detection in various settings.Impact:The impact of CRISPR/Cas۱۳ in bacterial detection extends beyond the laboratory. Its potential to revolutionize diagnostics and offer rapid, affordable, and accurate detection has implications for public health, clinical settings, and monitoring of infectious diseases. Early and precise identification of bacterial pathogens can lead to timely treatment, reduce the spread of antibiotic resistance, and ultimately save lives. It also has the potential to revolutionize food safety, agriculture, and environmental monitoring.CONCLUSIONCRISPR/Cas۱۳ technology has emerged as a game-changer in bacterial detection. Its ability to specifically target and cleave bacterial RNA sequences with high precision and sensitivity offers new avenues for rapid and accurate diagnostics. While challenges exist, ongoing research and innovation hold promise for overcoming these hurdles. The future integration of CRISPR/Cas۱۳ with other diagnostic technologies could lead to accessible and effective bacterial detection methods with significant impacts on healthcare and public health. With ongoing advancements, CRISPR/Cas۱۳ has the potential to transform the way we diagnose and manage bacterial infections, providing a powerful tool in our fight against infectious diseases.

نویسندگان

Moein Iranmanesh

Biology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran

Abbas Hajizade

Biology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran

Mostafa Zare

Biology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran

Mohsen yaghoubi

Biology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran

Mohammad Purghasem

Department of Medical Biotechnology, Faculty of Paramedicine, Guilan University of Medical Sciences, Langarud, Iran